{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:20:08Z","timestamp":1788787208088,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Centre Hospitalier Universitaire de Reims","award":["AOL 2015-11"],"award-info":[{"award-number":["AOL 2015-11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12253-020-00857-5","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T12:02:57Z","timestamp":1593000177000},"page":"2509-2521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expression of the Serrated Markers Annexin A10 or Gremlin1 in Colonic Adenocarcinomas: Morphology and Prognostic Values"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3444-1499","authenticated-orcid":false,"given":"Benjamin","family":"Marquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Marchal Bressenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Fichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bouland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Kianmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Dani\u00e8le","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Boulagnon-Rombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"857_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. \nhttps:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"857_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2559.2006.02548.x","volume":"50","author":"MJ M\u00e4kinen","year":"2007","unstructured":"M\u00e4kinen MJ (2007) Colorectal serrated adenocarcinoma. Histopathology 50:131\u2013150. \nhttps:\/\/doi.org\/10.1111\/j.1365-2559.2006.02548.x","journal-title":"Histopathology"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/crc.13.84","volume":"3","author":"MJ M\u00e4kinen","year":"2014","unstructured":"M\u00e4kinen MJ (2014) Serrated polyps and colorectal cancer risk. Colorectal Cancer 3:77\u201391. \nhttps:\/\/doi.org\/10.2217\/crc.13.84","journal-title":"Colorectal Cancer"},{"key":"857_CR4","unstructured":"Nagtegaal ID, Odze RD, Klimstra D et al (2019) WHO classification of tumours of the digestive system. In: WHO classification of tumours editorial board, 5th edn. Lyon, pp 157-192"},{"key":"857_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/path.1850","volume":"207","author":"K Tuppurainen","year":"2005","unstructured":"Tuppurainen K, M\u00e4kinen JM, Junttila O, Liakka A, Kyll\u00f6nen AP, Tuominen H, Karttunen TJ, M\u00e4kinen MJ (2005) Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 207:285\u2013294. \nhttps:\/\/doi.org\/10.1002\/path.1850","journal-title":"J Pathol"},{"key":"857_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00428-014-1683-6","volume":"466","author":"SA Sajanti","year":"2015","unstructured":"Sajanti SA, V\u00e4yrynen JP, Sirni\u00f6 P, Klintrup K, M\u00e4kel\u00e4 J, Tuomisto A, M\u00e4kinen MJ (2015) Annexin A10 is a marker for the serrated pathway of colorectal carcinoma. Virchows Arch 466:5\u201312. \nhttps:\/\/doi.org\/10.1007\/s00428-014-1683-6","journal-title":"Virchows Arch"},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/path.2400","volume":"216","author":"S Mussunoor","year":"2008","unstructured":"Mussunoor S, Murray G (2008) The role of annexins in tumour development and progression. J Pathol 216:131\u2013140. \nhttps:\/\/doi.org\/10.1002\/path.2400","journal-title":"J Pathol"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/bjc.2011.404","volume":"105","author":"PP Munksgaard","year":"2011","unstructured":"Munksgaard PP, Mansilla F, Brems Eskildsen A-S, Fristrup N, Birkenkamp-Demtr\u00f6der K, Ulh\u00f8i BP, Borre M, Agerb\u00e6k M, Hermann GG, \u00d8rntoft TF, Dyrskj\u00f8t L (2011) Low ANXA10 expression is associated with disease aggressiveness in bladder cancer. Br J Cancer 105:1379\u20131387. \nhttps:\/\/doi.org\/10.1038\/bjc.2011.404","journal-title":"Br J Cancer"},{"key":"857_CR9","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/ijc.24541","volume":"125","author":"J Kim","year":"2009","unstructured":"Kim J, Kim MA, Jee CD, Jung EJ, Kim WH (2009) Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma. Int J Cancer 125:1842\u20131850. \nhttps:\/\/doi.org\/10.1002\/ijc.24541","journal-title":"Int J Cancer"},{"key":"857_CR10","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0002-9440(10)61129-7","volume":"160","author":"S-H Liu","year":"2002","unstructured":"Liu S-H, Lin C-Y, Peng S-Y, Jeng YM, Pan HW, Lai PL, Liu CL, Hsu HC (2002) Down-regulation of Annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 160:1831\u20131837. \nhttps:\/\/doi.org\/10.1016\/S0002-9440(10)61129-7","journal-title":"Am J Pathol"},{"key":"857_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045510","volume":"7","author":"T Shimizu","year":"2012","unstructured":"Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K (2012) Annexin A10 in human oral cancer: biomarker for tumoral growth via G1\/S transition by targeting MAPK signaling pathways. PLoS One 7:e45510. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0045510","journal-title":"PLoS One"},{"key":"857_CR12","doi-asserted-by":"publisher","first-page":"9749","DOI":"10.3748\/wjg.v21.i33.9749","volume":"21","author":"JM Bae","year":"2015","unstructured":"Bae JM (2015) Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway. World J Gastroenterol 21:9749\u20139757. \nhttps:\/\/doi.org\/10.3748\/wjg.v21.i33.9749","journal-title":"World J Gastroenterol"},{"key":"857_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/apm.12284","volume":"122","author":"JH Kim","year":"2014","unstructured":"Kim JH, Rhee Y-Y, Kim K-J, Cho NY, Lee HS, Kang GH (2014) Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability. APMIS 122:1187\u20131195. \nhttps:\/\/doi.org\/10.1111\/apm.12284","journal-title":"APMIS"},{"key":"857_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/modpathol.2014.96","volume":"28","author":"J-H Tsai","year":"2015","unstructured":"Tsai J-H, Lin Y-L, Cheng Y-C, Chen CC, Lin LI, Tseng LH, Cheng ML, Liau JY, Jeng YM (2015) Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma. Mod Pathol 28:268\u2013278. \nhttps:\/\/doi.org\/10.1038\/modpathol.2014.96","journal-title":"Mod Pathol"},{"key":"857_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/his.13006","volume":"69","author":"A Pelli","year":"2016","unstructured":"Pelli A, V\u00e4yrynen JP, Klintrup K, M\u00e4kel\u00e4 J, M\u00e4kinen MJ, Tuomisto A, Karttunen TJ (2016) Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer. Histopathology 69:831\u2013838. \nhttps:\/\/doi.org\/10.1111\/his.13006","journal-title":"Histopathology"},{"issue":"3","key":"857_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12032-017-1073-4","volume":"35","author":"Y Yamasaki","year":"2018","unstructured":"Yamasaki Y, Ishigami S, Arigami T, Kita Y, Uchikado Y, Kurahara H, Kijima Y, Maemura K, Natsugoe S (2018) Expression of gremlin1 in gastric cancer and its clinical significance. Med Oncol 35(3):30. \nhttps:\/\/doi.org\/10.1007\/s12032-017-1073-4","journal-title":"Med Oncol"},{"key":"857_CR17","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours. In: Wiley-Blackwell, 7th edn. Chichester, West Sussex, UK, pp 309"},{"key":"857_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/PAS.0b013e318184cd55","volume":"33","author":"LM Wang","year":"2009","unstructured":"Wang LM, Kevans D, Mulcahy H, O\u02bcSullivan J, Fennelly D, Hyland J, O\u02bcDonoghue D, Sheahan K (2009) Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 33:134\u2013141. \nhttps:\/\/doi.org\/10.1097\/PAS.0b013e318184cd55","journal-title":"Am J Surg Pathol"},{"key":"857_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/PAI.0000000000000157","volume":"24","author":"C Boulagnon","year":"2016","unstructured":"Boulagnon C, Dudez O, Beaudoux O, Dalstein V, Kianmanesh R, Bouch\u00e9 O, Diebold MD (2016) BRAFV600E gene mutation in colonic adenocarcinomas. Immunohistochemical detection using tissue microarray and clinicopathologic characteristics: an 86 case series. Appl Immunohistochem Mol Morphol 24:88\u201396. \nhttps:\/\/doi.org\/10.1097\/PAI.0000000000000157","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"857_CR20","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.18632\/oncotarget.24225","volume":"9","author":"C Boulagnon-Rombi","year":"2018","unstructured":"Boulagnon-Rombi C, Schneider C, Leandri C, Jeanne A, Grybek V, Bressenot AM, Barbe C, Marquet B, Nasri S, Coquelet C, Fichel C, Bouland N, Bonnomet A, Kianmanesh R, Lebre AS, Bouch\u00e9 O, Diebold MD, Bellon G, Dedieu S (2018) LRP1 expression in colon cancer predicts clinical outcome. Oncotarget 9:8849\u20138869. \nhttps:\/\/doi.org\/10.18632\/oncotarget.24225","journal-title":"Oncotarget"},{"key":"857_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/00313029209068874","volume":"24","author":"JR Jass","year":"1992","unstructured":"Jass JR, Smith M (1992) Sialic acid and epithelial differentiation in colorectal polyps and cancer. A morphological, mucin and lectin histochemical study. Pathology 24:233\u2013242. \nhttps:\/\/doi.org\/10.3109\/00313029209068874","journal-title":"Pathology"},{"key":"857_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.humpath.2010.04.002","volume":"41","author":"J Garc\u00eda-Solano","year":"2010","unstructured":"Garc\u00eda-Solano J, P\u00e9rez-Guillermo M, Conesa-Zamora P, Acosta-Ortega J, Trujillo-Santos J, Cerezuela-Fuentes P, M\u00e4kinen MJ (2010) Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 41:1359\u20131368. \nhttps:\/\/doi.org\/10.1016\/j.humpath.2010.04.002","journal-title":"Hum Pathol"},{"key":"857_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000334837","volume":"79","author":"Y Shida","year":"2012","unstructured":"Shida Y, Fujimori T, Tanaka H, Fujimori Y, Kimura R, Ueda H, Ichikawa K, Tomita S, Nagata H, Kubota K, Tsubaki M, Kato H, Yao T, Sugai T, Sugihara K, Ohkura Y, Imura J (2012) Clinicopathological features of serrated adenocarcinoma defined by M\u00e4kinen in dukes\u2019 B colorectal carcinoma. Pathobiology 79:169\u2013174. \nhttps:\/\/doi.org\/10.1159\/000334837","journal-title":"Pathobiology"},{"key":"857_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2","volume":"193","author":"MJ M\u00e4kinen","year":"2001","unstructured":"M\u00e4kinen MJ, George SM, Jernvall P et al (2001) Colorectal carcinoma associated with serrated adenoma - prevalence, histological features, and prognosis. J Pathol 193:286\u2013294. \nhttps:\/\/doi.org\/10.1002\/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2","journal-title":"J Pathol"},{"key":"857_CR25","doi-asserted-by":"publisher","first-page":"35165","DOI":"10.18632\/oncotarget.16815","volume":"8","author":"C-T Lee","year":"2017","unstructured":"Lee C-T, Huang Y-C, Hung L-Y, Chow NH, Su PF, Ho CL, Tsai HW, Chen YL, Lin SC, Lin BW, Lin PC, Lee JC (2017) Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival. Oncotarget 8:35165\u201335175. \nhttps:\/\/doi.org\/10.18632\/oncotarget.16815","journal-title":"Oncotarget"},{"key":"857_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03821.x","volume":"58","author":"K Stefanius","year":"2011","unstructured":"Stefanius K, Ylitalo L, Tuomisto A, Kuivila R, Kantola T, Sirni\u00f6 P, Karttunen TJ, M\u00e4kinen MJ (2011) Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma: KRAS and BRAF in serrated adenocarcinoma. Histopathology 58:679\u2013692. \nhttps:\/\/doi.org\/10.1111\/j.1365-2559.2011.03821.x","journal-title":"Histopathology"},{"key":"857_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ijc.27674","volume":"132","author":"P Conesa-Zamora","year":"2013","unstructured":"Conesa-Zamora P, Garc\u00eda-Solano J, Garc\u00eda-Garc\u00eda F, Turpin MC, Trujillo-Santos J, Torres-Moreno D, Oviedo-Ram\u00edrez I, Carbonell-Mu\u00f1oz R, Mu\u00f1oz-Delgado E, Rodriguez-Braun E, Conesa A, P\u00e9rez-Guillermo M (2013) Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer 132:297\u2013307. \nhttps:\/\/doi.org\/10.1002\/ijc.27674","journal-title":"Int J Cancer"},{"key":"857_CR28","doi-asserted-by":"publisher","first-page":"14095","DOI":"10.18632\/oncotarget.7374","volume":"7","author":"JH Kim","year":"2016","unstructured":"Kim JH, Bae JM, Cho N-Y, Kang GH (2016) Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Oncotarget 7:14095\u201314111. \nhttps:\/\/doi.org\/10.18632\/oncotarget.7374","journal-title":"Oncotarget"},{"key":"857_CR29","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/ijc.27454","volume":"131","author":"J Garc\u00eda-Solano","year":"2012","unstructured":"Garc\u00eda-Solano J, Conesa-Zamora P, Carbonell P, Trujillo-Santos J, Torres-Moreno D D, Pag\u00e1n-G\u00f3mez I, Rodr\u00edguez-Braun E, P\u00e9rez-Guillermo M (2012) Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. Int J Cancer 131:1790\u20131799. \nhttps:\/\/doi.org\/10.1002\/ijc.27454","journal-title":"Int J Cancer"},{"key":"857_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/path.4200","volume":"230","author":"DH Gonzalo","year":"2013","unstructured":"Gonzalo DH, Lai KK, Shadrach B, Goldblum JR, Bennett AE, Downs-Kelly E, Liu X, Henricks W, Patil DT, Carver P, Na J, Gopalan B, Rybicki L, Pai RK (2013) Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma\/polyp. J Pathol 230:420\u2013429. \nhttps:\/\/doi.org\/10.1002\/path.4200","journal-title":"J Pathol"},{"key":"857_CR31","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.3174","volume":"19","author":"F De Sousa E Melo","year":"2013","unstructured":"De Sousa E Melo F, Wang X, Jansen M et al (2013) Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med 19:614\u2013618. \nhttps:\/\/doi.org\/10.1038\/nm.3174","journal-title":"Nat Med"},{"key":"857_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccr.2013.05.014","volume":"24","author":"R Rad","year":"2013","unstructured":"Rad R, Cadi\u00f1anos J, Rad L, Varela I, Strong A, Kriegl L, Constantino-Casas F, Eser S, Hieber M, Seidler B, Price S, Fraga MF, Calvanese V, Hoffman G, Ponstingl H, Schneider G, Yusa K, Grove C, Schmid RM, Wang W, Vassiliou G, Kirchner T, McDermott U, Liu P, Saur D, Bradley A (2013) A genetic progression model of BrafV600E-induced intestinal tumorigenesis reveals targets for therapeutic intervention. Cancer Cell 24:15\u201329. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2013.05.014","journal-title":"Cancer Cell"},{"key":"857_CR33","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, de Sousa E Melo F, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350\u20131356. \nhttps:\/\/doi.org\/10.1038\/nm.3967","journal-title":"Nat Med"},{"key":"857_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1506597","volume":"374","author":"P Dalerba","year":"2016","unstructured":"Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forg\u00f3 E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF (2016) CDX2 as a prognostic biomarker in stage II and stage III colon cancer. N Engl J Med 374:211\u2013222. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1506597","journal-title":"N Engl J Med"},{"key":"857_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clcc.2018.02.001","volume":"17","author":"G Tomasello","year":"2018","unstructured":"Tomasello G, Barni S, Turati L, Ghidini M, Pezzica E, Passalacqua R, Petrelli F (2018) Association of CDX2 expression with survival in early colorectal cancer: a systematic review and meta-analysis. Clin Colorectal Cancer 17:97\u2013103. \nhttps:\/\/doi.org\/10.1016\/j.clcc.2018.02.001","journal-title":"Clin Colorectal Cancer"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-020-00857-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-020-00857-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-020-00857-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:21:15Z","timestamp":1599142875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-020-00857-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s12253-020-00857-5","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"13 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethical standards. All patients had given their consent for biospecimen use and the study was performed in accordance with the ethical standards laid down in the Declaration of Helsinki. The written consent of patients to the biospecimen use was obtained in all cases. Approval for the study was previously obtained from the local Institutional Review Board and the Tissue Bank Management Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors have no conflict of interest to declare","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}